Formulation and Evaluation of Captopril Loaded Niosomal Transdermal Films
Pharmaceutical Science-Pharmaceutics
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.P143-155Keywords:
Bioavailability, Captopril, Niosomes, Non-Ionic Surfactants, Permeability, and, Transdermal Films.Abstract
Captopril was the first angiotensin-converting enzyme (ACE) inhibitor used for the management of hypertension. The aim of this study was to prepare and evaluate niosomal-loaded captopril transdermal films. Captopril has good solubility but has poor permeability and reduced bioavailability in the presence of food. The aim and objective are to improve bioavailability and permeability. The captopril-loaded niosomal formulations were prepared by thin film hydration technique, using materials like non-ionic surfactants such as Spans of different grades 20, 40, 60 and 80 and solvents like ethanol and chloroform. The FT-IR results revealed that there was no interaction between excipients and captopril. All the formulations showed better encapsulation efficiency. The dissolution studies showed prolonged drug release in comparison to pure captopril. On comprising all formulations, F3 showed sustained release of 98.44% up to 12hrs. The optimized niosomes of captopril were used to prepare transdermal films using methyl cellulose, HPMC E5, HPMC K4M and HPMC K15M as a film forming agents and dibutyl phthalate as a plasticizer. All the formulated captopril transdermal films were evaluated for drug content, folding endurance, weight variation and in-vitro drug permeation. The in-vitro drug permeation was found to be 99.58% over a period of 12 hrs. Based on the above results, administering niosomal-loaded captopril through the transdermal route is a better approach.
References
Duraivel S., Rajalakshmi A.N and Debjit Bhowmik. Formulation and evaluation of captopril Transdermal Patches. Elixir International Journal.2014; 76: 28209-28213. https://www.elixirpublishers.com/articles/1414820802_76%20(2014)%2028209-28213.pdf
Md. Khaja, Muneer Syed, D. Srinivasa Rao. Design, Development and Evaluation of Transdermal Drug Delivery of Captopril, an Antihypertensive Drug. Indo American Journal of Pharmaceutical Sciences. 2014; 1(5): 305-314. http://www.iajps.com/pdf/november/captopril.pdf
Darren R. Gullick, W. John Pugh, Matthew J. Ingram, Paul A. Cox and Gary P. Moss. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption. Drug Development and Industrial Pharmacy. 2010; 36(8): 926–932. https://doi.org/10.3109/03639040903585135.
Oya KERIMOGLU, Sevinç SAHBAZ, Özer SEHIRLI, Betül DORTUNÇ, Göksel SENER. Mechanical evaluation of matrix type transdermal therapeutic systems containing captopril. Marmara Pharmaceutical Journal. 2015; 19: 67-72. https://dergipark.org.tr/en/download/article-file/166071.
Goswami D. S., Uppal N. Formulation and Evaluation of Transdermal Delivery System of an Antihypertensive Drug. Journal of Applied Pharmaceutical Research. 2013; 1(1): 31-35. https://www.japtronline.com/index.php/joapr/article/view/1/5.
Eun-Seok Park, Seok-Jung Chang, Yun-Seok Rhee, and Sang-Cheol Chi. Effects of Adhesives and Permeation Enhancers on the Skin Permeation of Captopril. Drug Development and Industrial Pharmacy. 2001; 27(9): 975–980. DOI: 10.1081/ddc-100107679. PMID: 11763476.
Zhou XH, Li Wan PA. Stability and in-vitro absorption of captopril, enalapril and lisinopril across the rat intestine. Biochem Pharmacol. 1994; 47: 1121-1126.
Tripathi KD. Essentials of Medical Pharmacology. New Delhi, India, Jaypee Brothers, 2003 pp 449-454.
Ankur Gupta, Sunil Kumar Prajapati, M Balamurugan, Mamta Singh, Daksh Bhatia. Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril. Tropical Journal of Pharmaceutical Research. 2007; 6 (2): 687-693. doi: 10.4314/tjpr.v6i2.2.
Mariangela de Burgos M de Azevedo, Ljubica Tasic, Juliana Fattori, Fábio hs rodrigues, Fabiana c cantos, Leandro P ribeiro, Vanice de Paula, Danielle Ianzer and robson As santos. New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles. International Journal of Nanomedicine. 2011:6 1005–1016. DOI: 10.2147/IJN.S18999.
Wilding, I. R.; Davis, S. S.; Bkhshaee, M.; Stevens, H. N.; Sparrow, R. A. Gastrointestinal transit and systemic absorption of captopril from a pulsed released formulation. Pharm. Res. 1992, 9 (5): 654-657.
Ankur Gupta, Sunil Kr. Prajapati, Mamta Singh, and M. Balamurugan. Proniosomal Powder of Captopril: Formulation and Evaluation. Molecular Pharmaceutics, 2007, 4(4): 596-599. DOI: 10.1021/mp0700110.
Soumya Singh. Niosomes: A Role in Targeted Drug Delivery System. IJPSR, 2013; Vol. 4(2): 550-557. DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.4(2).550-57.
Manish Kumar Gupta, Dr. Deepak Prakash, Dr. Brahmeshwar Mishra. Development and Characterization of Microparticulated Drug Delivery System of Captopril. Indo American Journal of Pharm Research.2013; 3(10):8323-8332.
Angilicam Avinash, P. Dwarakanadha Reddy, S. V. Satyanarayana. Design and Evaluation of Captopril-loaded Niosomes. Asian Journal of Pharmaceutics. 2022; 16 (3): 261-267.DOI: https://doi.org/10.22377/ajp.v16i3.4475.
Nimesh Goswami, Paresh Prajapati. Quality by Design (QBD) to Optimization of Semi-Solid Suspension Type of Captopril Transdermal Drug Delivery System. International Journal of Research and Development in Pharmacy and Life Sciences. 2016; 5(2): 2023-2038. https://ubipayroll.com/IJRDPL/index.php/ijrdpl/article/view/215/217.
Shefrin S., Sreelaxmi C. S., Vishnu Vijayan, Sreeja C. Nair. Anti-Epileptic Drug Loaded Niosomal Transdermal Patch for Enhanced Skin Permeation. International Journal of Applied Pharmaceutics. 2019; 11(2): 31-43.https://doi.org/10.22159/ijap.2019v11i2.27034
Vandana Mohabe, Rachna Akhand and Anupam Kumar Pathak. Preparation and Evaluation of Captopril Transdermal Patches. Bulletin of Pharmaceutical Research.2011; 1(2):47-52. https://www.researchgate.net/publication/328213985_PREPARATION_AND_EVALUATION_OF_CAPTOPRIL_TRANSDERMAL_PATCHES.
Nukaraju K, Veerraju T and Satyavathi K, Formulation and Evaluation of Transdermal Patches of CetrizineDihydrochloride. International Journal of Pharmaceutical Sciences Review and Research. 2014; 25(1): 178-182. https://nanopdf.com/download/5b16c92650534_pdf
N. Swathi, D. Jayaprakash. Formulation Development and Evaluation of Captopril MouthDissolving Films. International Journal of ChemTech Research. 2019; 12(03): 17-27.
PravinUttekar, Akshata Kulkarni, Pravin Chaudhari, Manoj Dhage and Vishal Dhangarmali. Formulation and Evaluation of Captopril Transdermal patches for the treatment of hypertension. Der Pharmacia Lettre. 2016; 8 (5):12-16.https://www.scholarsresearchlibrary.com/articles/formulation-and-evaluation-of-captopril-transdermal-patches-for-thetreatment-of-hypertension.pdf
Vijayan V., Sumanth M.H., Suman L., Vinay T., SrinivasraoD., Jayaraj Kumar K, Development and Physiochemical, In-Vitro Evaluation of Antihypertensive Transdermal Patches, Journal of Pharmaceutical Sciences and Research, 2010, 2(3),171-177. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.295.1329&rep=rep1&type=pdf
Gajanan Darwhekar, Dinesh Kumar Jain, Vinod Kumar Patidar. Formulation and Evaluation of Transdermal Drug Delivery System of Clopidogrel Bisulfate. Asian Journal of Pharmacy and Life Science. 2011; 1(3):269-278. https://www.yumpu.com/en/document/view/31127487/formulation-and-evaluation-of-transdermal-drug-delivery-system-of-
NavneetVerma, ShikhaDeshwal,Design and In Vitro Evaluation of Transdermal Patches Containing Ketoprofen, World Journal of Pharmaceutical Research, 2014, 3(3), 3930-3944. https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1398843102.pdf
Anisree G.S, Ramasamy C, John Wesley.I, Bincy Mary Koshy. Formulation of Transdermal Drug Delivery System of Metoprolol Tartrate and its Evaluation. Journal Pharmaceutical Sciences & Research. 2012; 4(10):1939 – 1942. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.295.6387&rep=rep1&type=pdf
Roshan Kumar Dubey, Hitesh Kumar Dewangan. Rational Design and Characterization of Transdermal Patch of Irbesartan for Hypertension. Indian Journal of Pharmaceutical Education and Research. 2020; 54(3): 464-472. https://www.ijper.org/article/1259
Priyanka Kriplani, Abhishek Sharma, Aman, Pooja Pun, Bhawna Chopra, AshwaniDhingra and GeetaDeswal. Formulation and Evaluation of Transdermal Patch of Diclofenac Sodium. Global Journal of Pharmacy & Pharmaceutical Sciences. 2018; 4(5): 01-04. DOI: 10.19080/GJPPS.2018.04.555647.
Mohd. Amjad, Mohd. Ehtheshamuddin, S. Chand, Hanifa, M. Sabreesh, R. Asia, and G. S Kumar. Formulation and Evaluation of Transdermal Patches of Atenolol. Advance Research in Pharmaceuticals and Biologicals. 2011; 1(2): 109-119.https://arastirmax.com/en/system/files/dergiler/160852/makaleler/1/2/arastrmx_160852_1_pp_109-119.pdf
Hemul V. Patel, Jaimin D. Bhatt and Naynika K. Patel. Design and Development of Transdermal Drug Delivery for Anti-Hypertensive Drug Using Different Polymeric System. International Journal of Pharmaceutical and Chemical Sciences. 2013; 2(2):942-949.https://www.researchgate.net/publication/265259719_Design_and_Development_of_Transdermal_Drug_Delivery_for_Anti-Hypertensive_Drug_Using_Different_Polymeric_System
TejashreeChavan and Prajakta More. Formulation and Evaluation of Transdermal patch of Antihypertensive Drug. International Journal of Science and Research. 2018; 7(7): 562-566.
Verma Surender, Malik Vipul, Ashima. Formulation, evaluation and optimization of transdermal patches of losartan potassium. World Journal of Pharmaceutical Sciences. 2016; 4(5): 277-284.https://www.academia.edu/25197524/Formulation_evaluation_and_optimization_of_transdermal_patches_of_losartan_potassium
VemulaVaishnavi, I. Bala Tripura Sundari and Dr. M. Bhagavan Raju. Formulation and Evaluation of Telmisartan Loaded Ethosomal Patch. European Journal of Pharmaceutical and Medical Research, 2019; 6(11): 407-416. https://storage.googleapis.com/journal-uploads/ejpmr/article_issue/1572505805.pdf
Vaishali Y. Londhe and Kashmira B. Umalkar, Formulation Development and Evaluation of Fast Dissolving Film of Telmisartan, Indian Journal of Pharmaceutical Sciences, 2012, 74 (2), 122-126. doi: 10.4103/0250-474X.10384
S.C. Atram and Dr. S.D. Pande, A Statistical approach to the development of Telmisartan Transdermal Delivery System, Indo American Journal of Pharmaceutical Sciences, 2021, 08 (1), 1989-1998.https://www.iajps.com/wp-content/uploads/2021/01/410.IAJPS410012021.pdf
Swathi Palepu, Balli Sravanthi, Donthu Himabindu, GollapallyVenu Kumar, Jonnalagadda Rambabu, Dr T. Satyanarayana, Formulation and Evaluation of Pravastatin Sodium Transdermal Patch, Scholars Academic Journal of Pharmacy, 2017, 6(10), 440-445.https://saspublishers.com/media/articles/SAJP-610440-445.pdf
Rajesh Sreedharan Nair, Tai Nyet Ling, Mohamed Saleem Abdul Shukkoor, Balamurugan Manickam. Matrix type transdermal patches of captopril: Ex vivo permeation studies through excised rat skin. Journal of pharmacy research. 2013; 6: 774-779. http://dx.doi.org/10.1016/j.jopr.2013.07.003.
Shailesh T. Prajapati, Charmi G. Patel, and Chhagan N. Patel, Formulation and Evaluation of Transdermal Patch of Repaglinide, International Scholarly Research Network, 2011, 1-9. https://downloads.hindawi.com/archive/2011/651909.pdf.
M.D. Munoz, H. Castán, M.A. Ruiz, M.E. Morales, Design, development and characterization of transdermal patch of methadone, Journal of Drug Delivery Science and Technology. 2017; 42:1-6. https://doi.org/10.1016/j.jddst.2017.04.011.
Priyanka Arora, Biswajit Mukherjee, Design, Development, Physicochemical, and In Vitro and In Vivo Evaluation of Transdermal Patches Containing Diclofenac Diethylammonium Salt, Journal of Pharmaceutical Sciences, 2002, 91(9), 2076-2089. https://doi.org/10.1002/jps.10200.
Hany S.M. Ali, Ahmed F. Hanafy, Glibenclamide Nanocrystals in a Biodegradable Chitosan Patch for Transdermal Delivery: Engineering, Formulation, and Evaluation, Journal of Pharmaceutical Sciences, 2016, 402-410. http://dx.doi.org/10.1016/j.xphs.2016.10.010.
Dharmesh Trivedi, Anju Goyal. Formulation and evaluation of transdermal patches containing dexketoprofen Trometamol. International Journal of Pharmaceutical Chemistry and Analysis. 2020; 7(2):87–97. https://doi.org/10.18231/j.ijpca.2020.014.
S. Mutalik, N. Udupa, Glibenclamide Transdermal Patches: Physicochemical, Pharmacodynamic, and Pharmacokinetic Evaluations, Journal of Pharmaceutical Sciences, 2004, 93(6), 1577-1594. DOI: 10.1002/jps.20058.
Amandeep Singh and Alka Bali, Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride, Journal of Analytical Science and Technology, 2016, 7(25), 1-13. DOI 10.1186/s40543-016-0105-6
Srinivas Mutalik, Nayanabhirama Udupa, Sharath Kumar, Sunil Agarwal, Ganesh Subramanian, Averineni K. Ranjith, Glipizide matrix transdermal systems for diabetes mellitus: Preparation, in vitro and preclinical studies, Science direct, 2006, 79, 1568-1577. https://doi.org/10.1016/j.lfs.2006.05.002.
Darren R. Gullick, W. John Pugh, Matthew J. Ingram, Paul A. Coxand Gary P. Moss. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption. Drug Development and Industrial Pharmacy, 2010; 36(8): 926–932. DOI: 10.3109/03639040903585135.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Angilicam Avinash, P. Dwarakanadha Reddy, S. V. Satyanarayana
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
